A European provider in life science

Our vision is to improve people's lives by being a leading, value-adding partner in life science

Interim Report Q1 2023

Share price


Press Releases


  • Strong organic growth in both business areas

    AddLife started 2023 with a strong first quarter. Healthcare activity levels are clearly recovering in all markets and the number of elective surgical procedures is increasing. In 2021 and 2022, the company positioned itself to meet the demand that the increased number of elective procedures was expected to drive once the effects of the pandemic subsided. We are now seeing this development materialise, which in the quarter resulted in strong organic growth of 13 percent in the Medtech business area.


    Fredrik Dalborg Addlife 2023
  • AddLife General meeting 2023

    When: Thursday 4 May, 2023, 4.00 p.m.

    Where: World Trade Center, Room New York, Klarabergsviadukten 70, Stockholm


    Welcome to register:

    General meeting
    Adobestock 308561351

Our business areas



In the Medtech business area, the subsidiaries offer products and services in the field of medical technology, as well as assistive equipment for use in homecare. Medtech’s offering mainly focuses on public funded health care, homecare and social care in Europe.

Read more


The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. Customers include hospitals, research laboratories, pharmaceutical companies, and food industry groups, primarily in the Nordics and rest of Europe.

Read more

Join the AddLife group

Do you have a life science company with opportunities to grow? We offer an attractive option with a decentralized business model where we combine the strength of a large enterprise with the dedication and business skills of an entrepreneur. As an AddLife subsidiary you are responsible for your business activities within the AddLife requirements for growth, profitability and sustainable development.


News from our subsidiaries

Addlife Sustainability (1)
17 March 2023
Sustainability is caring for others

Triolab, part of AddLife group's sustainability programme, focuses on environmental responsibility, fair business practices, and employee well-being. By optimising logistics and adhering to strict regulations, the company ensures reliability and fosters lasting partnerships.

Triolab OY
31 January 2023 | Triolab OY
Triolab is prepared for power outages

Triolab is prepared for power outages to ensure continuous service in healthcare. With UPS devices securing data systems, grid-independent sensors monitoring storage conditions, and a diesel generator providing self-supplied electricity, Triolab maintains product functionality and operational continuity amidst disruptions.

31 January 2023 | HC21
O’Flynn Medical nominated for Green Small Organisation of the Year at the Green Awards

Great news for our O’Flynn Medical team who have been shortlisted for Green Small Organisation of the Year at the Green Awards. The Green Awards recognise the extraordinary contribution and commitment that companies now make towards growing a greener future in Ireland today.

30 January 2023 | Spectrum
Dry Eye Solutions added to Spectrum range

Spectrum Ophthalmics launches a brand-new range of Dry Eye Solutions, enhancing its comprehensive portfolio.

See all news

Sustainability for AddLife

Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value adding provider in life science. AddLife´s approach to sustainability is identified through three impact areas where we can have the greatest contribution to a long-term lasting business and society.

Adobestock 300716540